Subscribe to
this category
r

Strategy

A total of 41 posts are filed under Strategy
Akcea to Cut Workforce by 10 Percent After FDA Refuses to Approve FCS Drug
Rare Daily Staff Akcea Therapeutics said it is cutting its workforce by about 10 percent following the U.S. Food and Drug Administrations… Continue Reading
Sigilon Therapeutics Names Rare Disease Veteran Rogerio Vivaldi as CEO
Rare Daily Staff Sigilon Therapeutics said that it has named Rogerio Vivaldi as its CEO to replace Paul Wotton, who has stepped back from… Continue Reading
Aselage to Retire from Retrophin; Retrophin, Albireo appoint new CMOs
Rare Daily Staff Rare disease drug company Retrophin said its CEO Stephen Aselage will retire and that the company’s board of directors… Continue Reading
Abeona, Syntimmue Strengthen Leadership Teams
Rare Daily Staff Rare disease drug developers Abeona Therapeutics and Syntimmune both announced executive appointments to strengthen their… Continue Reading
CVC Capital Partners Buys Controlling Stake in Recordati for $3.5 Billion
Rare Daily Staff A consortium of funds led by CVC Capital Partners has agreed to buy a majority interest in drugmaker Recordati for $3.5… Continue Reading
Sanofi Genzyme Creates Challenge to Find Digital Technologies to Speed Rare Disease Diagnoses
Rare Daily Staff Sanofi Genzyme has issued a call for submissions for its Rare Innovation Challenge, an effort to find innovative digital… Continue Reading
MHRA Grants MeiraGTx License for London Manufacturing Facility
Rare Daily Staff MeiraGTx The U.K.’s Medicines and Healthcare products Regulatory Agency granted MeiraGTx a Manufacturer’s Authorization… Continue Reading
1 2 3 6
be-a-guest-blogger

Follow us on Twitter